BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 26119304)

  • 1. Hypericum Perforatum Hydroalcoholic Extract Mitigates Motor Dysfunction and is Neuroprotective in Intrastriatal 6-Hydroxydopamine Rat Model of Parkinson's Disease.
    Kiasalari Z; Baluchnejadmojarad T; Roghani M
    Cell Mol Neurobiol; 2016 May; 36(4):521-30. PubMed ID: 26119304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective Effect of Oral Hesperetin Against Unilateral Striatal 6-Hydroxydopamine Damage in the Rat.
    Kiasalari Z; Khalili M; Baluchnejadmojarad T; Roghani M
    Neurochem Res; 2016 May; 41(5):1065-72. PubMed ID: 26700436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetyl-l-carnitine protects dopaminergic nigrostriatal pathway in 6-hydroxydopamine-induced model of Parkinson's disease in the rat.
    Afshin-Majd S; Bashiri K; Kiasalari Z; Baluchnejadmojarad T; Sedaghat R; Roghani M
    Biomed Pharmacother; 2017 May; 89():1-9. PubMed ID: 28199883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anti-aging protein klotho alleviates injury of nigrostriatal dopaminergic pathway in 6-hydroxydopamine rat model of Parkinson's disease: Involvement of PKA/CaMKII/CREB signaling.
    Baluchnejadmojarad T; Eftekhari SM; Jamali-Raeufy N; Haghani S; Zeinali H; Roghani M
    Exp Gerontol; 2017 Dec; 100():70-76. PubMed ID: 29107062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Troxerutin exerts neuroprotection in 6-hydroxydopamine lesion rat model of Parkinson's disease: Possible involvement of PI3K/ERβ signaling.
    Baluchnejadmojarad T; Jamali-Raeufy N; Zabihnejad S; Rabiee N; Roghani M
    Eur J Pharmacol; 2017 Apr; 801():72-78. PubMed ID: 28284752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
    Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sesamin imparts neuroprotection against intrastriatal 6-hydroxydopamine toxicity by inhibition of astroglial activation, apoptosis, and oxidative stress.
    Baluchnejadmojarad T; Mansouri M; Ghalami J; Mokhtari Z; Roghani M
    Biomed Pharmacother; 2017 Apr; 88():754-761. PubMed ID: 28157651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypericum polyanthemum cyclohexane extract potentiates behavioral effects and neurodegeneration induced by nigral infusions of 6-hydroxydopamine in rats.
    Borsoi M; Batassini C; Lazzaretti C; Silvestrin RB; Betti AH; Stein AC; von Poser GL; Rates SMK; Souza TME
    Neurosci Lett; 2018 Nov; 687():177-182. PubMed ID: 30266672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ellagic acid exerts protective effect in intrastriatal 6-hydroxydopamine rat model of Parkinson's disease: Possible involvement of ERβ/Nrf2/HO-1 signaling.
    Baluchnejadmojarad T; Rabiee N; Zabihnejad S; Roghani M
    Brain Res; 2017 May; 1662():23-30. PubMed ID: 28238669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the antiparkinsonism and neuroprotective effects of hydrogen sulfide in acute 6-hydroxydopamine-induced animal model of Parkinson's disease: behavioral, histological and biochemical studies.
    Sarukhani M; Haghdoost-Yazdi H; Sarbazi Golezari A; Babayan-Tazehkand A; Dargahi T; Rastgoo N
    Neurol Res; 2018 Jul; 40(7):523-531. PubMed ID: 29726751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective Properties of Standardized Extracts of Hypericum perforatum on Rotenone Model of Parkinson's Disease.
    Gómez del Rio MA; Sánchez-Reus MI; Iglesias I; Pozo MA; García-Arencibia M; Fernández-Ruiz J; García-García L; Delgado M; Benedí J
    CNS Neurol Disord Drug Targets; 2013 Aug; 12(5):665-79. PubMed ID: 23469842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral profile of Hypericum perforatum (St. John's Wort) extract. A comparison with standard antidepressants in animal models of depression.
    Bukhari IA; Dar A
    Eur Rev Med Pharmacol Sci; 2013 Apr; 17(8):1082-9. PubMed ID: 23661522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective and neurotrophic effect of apomorphine in the striatal 6-OHDA-lesion rat model of Parkinson's disease.
    Yuan H; Sarre S; Ebinger G; Michotte Y
    Brain Res; 2004 Nov; 1026(1):95-107. PubMed ID: 15476701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of ethanolic extract of Delphinium denudatum in a rat model of Parkinson's disease.
    Ahmad M; Yousuf S; Khan MB; Ahmad AS; Saleem S; Hoda MN; Islam F
    Hum Exp Toxicol; 2006 Jul; 25(7):361-8. PubMed ID: 16898164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective effect of the methanolic extract of Hibiscus asper leaves in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Hritcu L; Foyet HS; Stefan M; Mihasan M; Asongalem AE; Kamtchouing P
    J Ethnopharmacol; 2011 Sep; 137(1):585-91. PubMed ID: 21704692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of adenosine triphosphate-sensitive potassium channels in the neuroprotective activity of hydrogen sulfide in the 6-hydroxydopamine-induced animal model of Parkinson's disease.
    Sarookhani MR; Haghdoost-Yazdi H; Sarbazi-Golezari A; Babayan-Tazehkand A; Rastgoo N
    Behav Pharmacol; 2018 Jun; 29(4):336-343. PubMed ID: 29239973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective effect of combined therapy with hyperbaric oxygen and madopar on 6-hydroxydopamine-induced Parkinson's disease in rats.
    Pan X; Chen C; Huang J; Wei H; Fan Q
    Neurosci Lett; 2015 Jul; 600():220-5. PubMed ID: 26101828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of robust protective effect of quercetin in two types of 6-hydroxydopamine-induced parkinsonian models in rats and dopaminergic cell cultures.
    Kääriäinen TM; Piltonen M; Ossola B; Kekki H; Lehtonen S; Nenonen T; Lecklin A; Raasmaja A; Männistö PT
    Brain Res; 2008 Apr; 1203():149-59. PubMed ID: 18329008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats.
    Jin F; Wu Q; Lu YF; Gong QH; Shi JS
    Eur J Pharmacol; 2008 Dec; 600(1-3):78-82. PubMed ID: 18940189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective and therapeutic activity of honokiol in reversing motor deficits and neuronal degeneration in the mouse model of Parkinson's disease.
    Chen HH; Chang PC; Chen C; Chan MH
    Pharmacol Rep; 2018 Aug; 70(4):668-676. PubMed ID: 29909247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.